Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP878751.RAvtYox7utPLtgC54r_sUE4k4z5VzHGKGRvS05ZT-UVPo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP878751.RAvtYox7utPLtgC54r_sUE4k4z5VzHGKGRvS05ZT-UVPo130_assertion type Assertion NP878751.RAvtYox7utPLtgC54r_sUE4k4z5VzHGKGRvS05ZT-UVPo130_head.
- NP878751.RAvtYox7utPLtgC54r_sUE4k4z5VzHGKGRvS05ZT-UVPo130_assertion wasGeneratedBy ECO_0000203 NP878751.RAvtYox7utPLtgC54r_sUE4k4z5VzHGKGRvS05ZT-UVPo130_provenance.
- NP878751.RAvtYox7utPLtgC54r_sUE4k4z5VzHGKGRvS05ZT-UVPo130_assertion wasDerivedFrom befree-2016 NP878751.RAvtYox7utPLtgC54r_sUE4k4z5VzHGKGRvS05ZT-UVPo130_provenance.
- NP878751.RAvtYox7utPLtgC54r_sUE4k4z5VzHGKGRvS05ZT-UVPo130_assertion SIO_000772 21394100 NP878751.RAvtYox7utPLtgC54r_sUE4k4z5VzHGKGRvS05ZT-UVPo130_provenance.
- NP878751.RAvtYox7utPLtgC54r_sUE4k4z5VzHGKGRvS05ZT-UVPo130_assertion evidence source_evidence_literature NP878751.RAvtYox7utPLtgC54r_sUE4k4z5VzHGKGRvS05ZT-UVPo130_provenance.
- NP878751.RAvtYox7utPLtgC54r_sUE4k4z5VzHGKGRvS05ZT-UVPo130_assertion description "[Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP878751.RAvtYox7utPLtgC54r_sUE4k4z5VzHGKGRvS05ZT-UVPo130_provenance.